Chemoprevention of cancer: Phenolic antioxidants (BHT, BHA)

International Journal of Biochemistry

Volumn 20, Issue 7, 1988, Pages 639-651

  Hocman, Gabriel ^a  

^a Research Institute of Preventive Medicine ^*  (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; ETHOXYQUIN; FOOD ADDITIVE; GALLIC ACID PROPYL ESTER; PYROGALLOL; RESORCINOL;

ANIMAL EXPERIMENT; CANCER; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; HUMAN; HUMAN EXPERIMENT; NONHUMAN; REVIEW;

ANIMAL; BUTYLATED HYDROXYANISOLE; BUTYLATED HYDROXYTOLUENE; CARCINOGENS; FOOD ADDITIVES; FORECASTING; HUMAN; NEOPLASMS;

EID: 0023950295     PISSN: 0020711X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-711X(88)90158-9     Document Type: Review

References (65)

1. Effects of BHA and related phenols on the forestomach of rats
2. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole
3. Comparative effect on the induction of the subunits of rat liver glutathione-S-transferases by butylated hydroxytoluene
4. Butylated hydroxytoluene (BHT) a review
5. Anti-oxidants and the immune response
6. Elevation of hepatic glutathione-S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants
7. Studies on the photoprotective mechanism of butylated hydroxytoluene
8. Relation of antioxidants and level of dietary lipid to epidermal lipid peroxidation and ultraviolet carcinogenesis
9. Screening of antioxidants and other compounds for antimutagenic properties towards benzo(a)pyrene-induced mutagenicity in strain TA 98 of Salmonella typhimurium
10. Kinetics of 3-tert-butyl-4-hydroxyanisole (BHA) in man
11. Effects of butylated hydroxytoluene (BHT) on bilinary excretion of xenobiotics and bile flow in rats
12. Effects of butylated hydroxyanisole on the tumorigenicity and metabolism of N-nitroso-dimethylamine and N-nitrosopyrrolidine in A/J mice
13. Effects of the antioxidant butylated hydroxytoluene (BHT) on mortality in BALB/c mice
14. Effects of butylated hydroxytoluene alone or with diethylnitrosamine in mice
15. Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interactions among BHT concentration, carcinogen dose and diet
16. Levels of BHA and BHT in human and animal adipose tissue: interspecies extrapolation
17. Metabolic aspects of antioxidants and preservatives
18. Protective effect of butylated hydroxytoluene on Adriamycin-induced skin necrosis in the rat
19. Induction of NAD(P)Hquinone reductase in murine hepatoma cells by phenolic antioxidants azo dyes and other chemoprotectors a model system for the study of anticarcinogens
20. Modifications ofmicrosomal and nuclear fractions by butylated hydroxyanisole and its effect on benzo(a)pyrene metabolites binding to macromolecules
21. Effects of multiple putative anticarcinogens on the carcinogenicity of trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-oxadizole
22. 1 in the lactating rat
23. Modifying effects of butylated hydroxyanisole, di(2-ethylhexyl)phthalate or indomethacin on mouse hepatocarcinogenesis initiated by N-nitrosodiethylamine
24. Combined effects of butylated hydroxyanisole and other antioxidants in induction of forestomach lesions in rats
25. Effect ofbutylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(a)pyrene: DNA adduct formation in vivo in the forestomach, lung and liver of mice
26. Promoting activities of butylated hydroxy-anisole, butylated hydroxytoluene and sodium 1-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats
27. Carcinogenicity of butylated hydroxyanisole in F344 rats
28. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis
29. Induction of forestomach hyperplasia by crude butylated hydroxyanisole, a mixture of 3-tert and 2-tert isomers, in Syrian golden hamsters is due to 3-tert-butylated hydroxyanisole
30. A 12-week study of BHA in the cynomolgus monkey
31. Enhancement of epoxide hydratase activity in rat lung, kidney and liver by dietary antioxidants
32. The dual role of antioxidants in the modification of chemical carcinogenesis
33. Effect of protein deficiency and Tween 60 on the pharmacokinetics of butylated hydroxy-anisole and metabolites in male Sprague-Dawley rats
34. Possibilities for dietary fat and antioxidants as modulators of mammary carcinogenesis
35. The effects of dietary butylated hydroxytoluene on liver and colon tumor development in mice
36. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation
37. Effects of strain and age on prophylaxis and co-carcinogenesis or urethan-induced mouse lung adenomas by butylated hydroxytoluene
38. Changes in pulmonary adenosine triphosphate-binding proteins detected by nucleotide photoaffinity labeling following treatment of mice with the tumor-modulatory agent butylated hydroxytoluene
39. Evidence that the effectiveness of antioxidants as inhibitors of 7,12-dimethylbenz(a)anthracene-indueed mammary tumors is a function of dietary fat composition
40. Combination chemoprevention of rat mammary carcinogenesis by Indomethacin and butylated hydroxytoluene
41. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomittant or postcarcinogen antioxidant exposure
42. Anticarcinogenic and hepatotoxic interactions between retinyl acetate and butylated hydroxytoluene in rats
43. Pneumotoxicity ofbutylated hydroxytoluene applied dermally to CD-1 mice
44. Effects of single-dose and repeated-dose pretreatment with 2(3)-tert-butyl-4-hydroxyanisole (BHA) on the hepatobiliary disposition and covalent binding to DNA of aflatoxin Bi in the rat
45. Carcinogenicity study on butylated hydroxytoluene (BHT) in Wistar rats exposed in utero
46. Inhibition of mutagenicity of benzo(a)pyrene in the V79/HGPRT system by bioantioxidants
47. Increased antimutagenic activity of simple substituted phenols mixed with the hindered phenolic antioxidant dibunol
48. Modulation of benzo(a)pyrene-induced morphological transformation of Syrian hamster embryo cells by butylated hydroxytoluene and butylated hydroxyanisole
49. Hepatic responses to the administration of high doses of BHT to the rat: their relevance to hepatocarcinogenity
50. Inhibition of cellular antioxidants: a possible mechanism of toxic cell injury
51. Inhibitors of mutagenesis and their relevance to carcinogenesis (International commission for protection against environmental mutagens and carcinogens, publication No. 12)
52. Modulation of azaserine-induced pancreatic foci by phenolic antioxidants in rats
53. Regioselective inhibition of benzo(a)pyren metabolism by butylated hydroxyanisole
54. Effects of four antioxidants on N-methyl-N'-nitro-N-nitrosoguanidine initiated gastric tumor
55. 3H-butylated hydroxyanisole in female mice
56. Methods of extraction and high-performance liquid Chromatographic analysis of butylated hydroxytoluene from the tissues and serum of rats
57. Six-month toxicity study of butylated hydroxyanisole in beagle dogs
58. Chemoprevention of cancer
59. Protective effects of 2(3)-tert-butyl-4-hydroxyanisole on chemical carcinogenesis
60. Neoplastic effects of oral administration of ( ±)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene and their inhibition by butylated hydroxyanisole
61. Epigenetic promoting effects of butylated hydroxyanisole
62. Simultaneous inhibition of liver careinogenicity and enhancement of bladder carcinogenicity of N-2-fluorenylacetamide by butylated hydroxytoluene
63. 1 induced hepatocarcinogenesis by the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene
64. BHA study in pigs
65. Chronic study on BHT in rats